Cargando…

Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements

The identification of MYC rearrangements in several mature B-cell neoplasms is critical for diagnostic and prognostic purposes. Commercially available fluorescence in situ hybridization (FISH) probe sets, including IGH/MYC dual-color dual-fusion (D-FISH) and MYC break-apart probes (BAPs), serve as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Jess F., Pitel, Beth A., Smoley, Stephanie A., Vasmatzis, George, Smadbeck, James B., Greipp, Patricia T., Ketterling, Rhett P., Macon, William R., Baughn, Linda B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549546/
https://www.ncbi.nlm.nih.gov/pubmed/31160360
http://dx.doi.org/10.1101/mcs.a004077
_version_ 1783424027071610880
author Peterson, Jess F.
Pitel, Beth A.
Smoley, Stephanie A.
Vasmatzis, George
Smadbeck, James B.
Greipp, Patricia T.
Ketterling, Rhett P.
Macon, William R.
Baughn, Linda B.
author_facet Peterson, Jess F.
Pitel, Beth A.
Smoley, Stephanie A.
Vasmatzis, George
Smadbeck, James B.
Greipp, Patricia T.
Ketterling, Rhett P.
Macon, William R.
Baughn, Linda B.
author_sort Peterson, Jess F.
collection PubMed
description The identification of MYC rearrangements in several mature B-cell neoplasms is critical for diagnostic and prognostic purposes. Commercially available fluorescence in situ hybridization (FISH) probe sets, including IGH/MYC dual-color dual-fusion (D-FISH) and MYC break-apart probes (BAPs), serve as the primary methodology utilized to detect MYC rearrangements. However, performing either IGH/MYC D-FISH or MYC BAP FISH studies in isolation has been reported to result in false-negative results because of the complex nature of 8q24 rearrangements involving the MYC gene region. We report a 60-yr-old male with newly diagnosed high-grade B-cell lymphoma with a negative MYC BAP study, but with positive BCL2 and BCL6 BAP studies. Per our current laboratory algorithm to concurrently interrogate the MYC gene region with both MYC BAP and IGH/MYC D-FISH probe sets, we performed IGH/MYC D-FISH studies and detected an IGH/MYC fusion. To further characterize the discrepant MYC results obtained by FISH, a next-generation sequencing strategy, mate-pair sequencing (MPseq), was performed and revealed a small insertion (∼200 kb) of the IGH locus downstream from the MYC gene that was undetectable by MYC BAP studies. This case highlights the importance of utilizing both IGH/MYC D-FISH and MYC BAP sets to detect potential cryptic MYC rearrangements and also demonstrates the power of MPseq to characterize complex structural rearrangements and copy-number abnormalities unappreciable by FISH.
format Online
Article
Text
id pubmed-6549546
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-65495462019-06-19 Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements Peterson, Jess F. Pitel, Beth A. Smoley, Stephanie A. Vasmatzis, George Smadbeck, James B. Greipp, Patricia T. Ketterling, Rhett P. Macon, William R. Baughn, Linda B. Cold Spring Harb Mol Case Stud Research Report The identification of MYC rearrangements in several mature B-cell neoplasms is critical for diagnostic and prognostic purposes. Commercially available fluorescence in situ hybridization (FISH) probe sets, including IGH/MYC dual-color dual-fusion (D-FISH) and MYC break-apart probes (BAPs), serve as the primary methodology utilized to detect MYC rearrangements. However, performing either IGH/MYC D-FISH or MYC BAP FISH studies in isolation has been reported to result in false-negative results because of the complex nature of 8q24 rearrangements involving the MYC gene region. We report a 60-yr-old male with newly diagnosed high-grade B-cell lymphoma with a negative MYC BAP study, but with positive BCL2 and BCL6 BAP studies. Per our current laboratory algorithm to concurrently interrogate the MYC gene region with both MYC BAP and IGH/MYC D-FISH probe sets, we performed IGH/MYC D-FISH studies and detected an IGH/MYC fusion. To further characterize the discrepant MYC results obtained by FISH, a next-generation sequencing strategy, mate-pair sequencing (MPseq), was performed and revealed a small insertion (∼200 kb) of the IGH locus downstream from the MYC gene that was undetectable by MYC BAP studies. This case highlights the importance of utilizing both IGH/MYC D-FISH and MYC BAP sets to detect potential cryptic MYC rearrangements and also demonstrates the power of MPseq to characterize complex structural rearrangements and copy-number abnormalities unappreciable by FISH. Cold Spring Harbor Laboratory Press 2019-06 /pmc/articles/PMC6549546/ /pubmed/31160360 http://dx.doi.org/10.1101/mcs.a004077 Text en © 2019 Peterson et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.
spellingShingle Research Report
Peterson, Jess F.
Pitel, Beth A.
Smoley, Stephanie A.
Vasmatzis, George
Smadbeck, James B.
Greipp, Patricia T.
Ketterling, Rhett P.
Macon, William R.
Baughn, Linda B.
Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title_full Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title_fullStr Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title_full_unstemmed Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title_short Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
title_sort elucidating a false-negative myc break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade b-cell lymphoma with igh/myc and igh/bcl2 rearrangements
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549546/
https://www.ncbi.nlm.nih.gov/pubmed/31160360
http://dx.doi.org/10.1101/mcs.a004077
work_keys_str_mv AT petersonjessf elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT pitelbetha elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT smoleystephaniea elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT vasmatzisgeorge elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT smadbeckjamesb elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT greipppatriciat elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT ketterlingrhettp elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT maconwilliamr elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements
AT baughnlindab elucidatingafalsenegativemycbreakapartfluorescenceinsituhybridizationprobestudybynextgenerationsequencinginapatientwithhighgradebcelllymphomawithighmycandighbcl2rearrangements